A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production
<i>Fasciola hepatica</i> is helminth parasite found around the world that causes fasciolosis, a chronic disease affecting mainly cattle, sheep, and occasionally humans. Triclabendazole is the drug of choice to treat this parasite. However, the continuous use of this drug has led to the d...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Articulo |
Lenguaje: | Inglés |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/124518 |
Aporte de: |
id |
I19-R120-10915-124518 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Ciencias Médicas Ciencias Exactas Veterinaria Th17-dependent protection nanostructure ascorbyl palmitate kunitz type molecule vaccine Fasciola hepatica |
spellingShingle |
Ciencias Médicas Ciencias Exactas Veterinaria Th17-dependent protection nanostructure ascorbyl palmitate kunitz type molecule vaccine Fasciola hepatica Silvane, Leonardo Micael Celias, Daiana Pamela Romagnoli, Pablo Alberto Maletto, Belkys Angélica Sánchez Vallecillo, María Fernanda Chiapello, Laura Silvina Palma, Santiago Daniel Allemandi, Daniel Alberto Sanabria, Rodrigo Eduardo Fabrizio Pruzzo, César Iván Motrán, Claudia Cristina Cervi, Laura A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
topic_facet |
Ciencias Médicas Ciencias Exactas Veterinaria Th17-dependent protection nanostructure ascorbyl palmitate kunitz type molecule vaccine Fasciola hepatica |
description |
<i>Fasciola hepatica</i> is helminth parasite found around the world that causes fasciolosis, a chronic disease affecting mainly cattle, sheep, and occasionally humans. Triclabendazole is the drug of choice to treat this parasite. However, the continuous use of this drug has led to the development of parasite resistance and, consequently, the limitation of its effectiveness. Hence, vaccination appears as an attractive option to develop. In this work, we evaluated the potential of <i>F. hepatica</i> Kunitz-type molecule (FhKTM) as an antigen formulated with a liquid crystal nanostructure formed by self-assembly of 6-O-ascorbyl palmitate ester (Coa-ASC16) and the synthetic oligodeoxynucleotide containing unmethylated cytosine-guanine motifs (CpG-ODN) during an experimental model of fasciolosis in mice, and we further dissected the immune response associated with host protection. Our results showed that immunization of mice with FhKTM/CpG-ODN/Coa-ASC16 induces protection against <i>F. hepatica</i> challenge by preventing liver damage and improving survival after <i>F. hepatica</i> infection. FhKTM/CpG-ODN/Coa-ASC16-immunized mice elicited potent IFN-γ and IL-17A with high levels of antigen-specific IgG1, IgG2a, and IgA serum antibodies. Strikingly, IL-17A blockade during infection decreased IgG2a and IgA antibody levels as well as IFN-γ production, leading to an increase in mortality of vaccinated mice. The present study highlights the potential of a new vaccine formulation to improve control and help the eradication of <i>F. hepatica</i> infection, with potential applications for natural hosts such as cattle and sheep. |
format |
Articulo Articulo |
author |
Silvane, Leonardo Micael Celias, Daiana Pamela Romagnoli, Pablo Alberto Maletto, Belkys Angélica Sánchez Vallecillo, María Fernanda Chiapello, Laura Silvina Palma, Santiago Daniel Allemandi, Daniel Alberto Sanabria, Rodrigo Eduardo Fabrizio Pruzzo, César Iván Motrán, Claudia Cristina Cervi, Laura |
author_facet |
Silvane, Leonardo Micael Celias, Daiana Pamela Romagnoli, Pablo Alberto Maletto, Belkys Angélica Sánchez Vallecillo, María Fernanda Chiapello, Laura Silvina Palma, Santiago Daniel Allemandi, Daniel Alberto Sanabria, Rodrigo Eduardo Fabrizio Pruzzo, César Iván Motrán, Claudia Cristina Cervi, Laura |
author_sort |
Silvane, Leonardo Micael |
title |
A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
title_short |
A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
title_full |
A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
title_fullStr |
A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
title_full_unstemmed |
A Vaccine Based on Kunitz-Type Molecule Confers Protection Against <i>Fasciola hepatica</i> Challenge by Inducing IFN-γ and Antibody Immune Responses Through IL-17A Production |
title_sort |
vaccine based on kunitz-type molecule confers protection against <i>fasciola hepatica</i> challenge by inducing ifn-γ and antibody immune responses through il-17a production |
publishDate |
2020 |
url |
http://sedici.unlp.edu.ar/handle/10915/124518 |
work_keys_str_mv |
AT silvaneleonardomicael avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT celiasdaianapamela avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT romagnolipabloalberto avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT malettobelkysangelica avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT sanchezvallecillomariafernanda avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT chiapellolaurasilvina avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT palmasantiagodaniel avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT allemandidanielalberto avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT sanabriarodrigoeduardofabrizio avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT pruzzocesarivan avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT motranclaudiacristina avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT cervilaura avaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT silvaneleonardomicael vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT celiasdaianapamela vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT romagnolipabloalberto vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT malettobelkysangelica vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT sanchezvallecillomariafernanda vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT chiapellolaurasilvina vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT palmasantiagodaniel vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT allemandidanielalberto vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT sanabriarodrigoeduardofabrizio vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT pruzzocesarivan vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT motranclaudiacristina vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction AT cervilaura vaccinebasedonkunitztypemoleculeconfersprotectionagainstifasciolahepaticaichallengebyinducingifngandantibodyimmuneresponsesthroughil17aproduction |
bdutipo_str |
Repositorios |
_version_ |
1764820450545762305 |